Print the page
Increase font size

Posted February 22, 2021

Byron King

By Byron King

Spotlight on Small-Cap Stocks

Aaron GentzlerBitcoin has value only because enough people deem it has value, says our contributor today.

There is a lot to Bitcoins scarcity argument because of the limited number of coins, but with so many other cryptos out there, you dont know which will survive and which will fail.

So why wont Bitcoin Cash take over from Bitcoin if enough people decide to move into this digital currency?

Personally, I dont believe Bitcoin will be the one to thrive in the end. Remember AOL or Netscape? These were some of the top dot-com businesses in the 90s; Bitcoin might follow in their footsteps.

I am a believer in blockchain technology, but I dont believe just one crypto will take over the world. Unlike gold, which is a singular element.

Until someone can prove to me without a doubt that Bitcoin will be the one and only, then I will not buy it. In fact, I think Ethereum has a better future than Bitcoin.

Per scarcity, the maximum number of Bitcoins is capped at 21 million. Currently, there are about 2 million Bitcoins left to be mined. Well take a deeper dive into Bitcoin Cash and Ethereum on Wednesday

Send your opinions to, TheRundownFeedback@SevenFigurePublishing.com.

Your Rundown for Monday, Feb. 22, 2021

Spotlight: Russell 2000

The markets turning the spotlight on small-cap stocks, and has been since November of last year.

Take for example, the Russell 2000 index, up more than 47% since that time. By comparison, the S&P 500 is up just 15% for the same time period.

For months during the pandemic, The Financial Times says, investors favoured fast-growing tech stocks that were the winners of a shift towards working and shopping online.

But Novembers Covid-19 vaccine breakthroughs prompted investors to shift towards the Russell 2000.

Investors have started to see the light at the end of the tunnel and think about the world post-lockdowns, says BlackRocks Russ Koesterich.

[This is interesting: dont just think biotech in relation to small-cap stocks and pandemic recovery. The Russell 2000 is more heavily weighted to financial stocks at about 14% -- compared with about 10% for the S&P 500, FT says.

The small-cap index also leans more towards regional banks that are exposed to traditional lending, while the larger financials on the blue-chip index have a greater bias to trading and investment banking.]

That being said, do small-cap stocks still have room to rally? According to Barrons: The key factors are excess liquidity, lower valuations, and prospects for more government spending as Democrats forge ahead with a $1.9 trillion economic revival package.

As for the last, the next stimulus package seems to be a lock. House Democrats unveiled the most recent version of President Joe Biden's $1.9 trillion stimulus bill on Friday, CNET reports. [Their] aggressive timeline would deliver a new stimulus payment as soon as next month.

All to say, theres more to the Russell 2000s boom. Easy exposure? iShares Russell 2000 ETF (ticker: IWM).

Market Rundown for Monday, Feb. 22, 2021

S&P 500 futures are down 32 points to 3,870.

Oil is up 2.3% to $60.60 for a barrel of West Texas crude.

Golds up 1% to $1,795.50 per ounce.

Bitcoin is letting off steam this morning: down 11% to $51,250.

Send your comments and questions to, TheRundownFeedback@SevenFigurePublishing.com.

Well talk more Wednesday. Hope your weeks off to a good start

For the Rundown,

Aaron Gentzler

Aaron Gentzler

Novavax: Competitive Advantages ‘Boost’ Profits

Posted June 14, 2021

By Aaron Gentzler

Novavax announced its Covid-19 vaccine… So what’s next for the Maryland-based biotech company?
Make America Competitive Again

Make America Competitive Again

Posted June 11, 2021

The Senate passed the U.S. Innovation and Competition Act (USICA). The bill aspires to make America competitive again… and takes aim at China.
Biogen Breaks Through 5-Year Stalemate

Biogen Breaks Through 5-Year Stalemate

Posted June 09, 2021

“This could be a key moment for the biotech sector,” says our chief market analyst Greg Guenthner.
Small Business Taxed for Pandemic Shortfalls

Small Business Taxed for Pandemic Shortfalls

Posted June 07, 2021

By Aaron Gentzler

Small businesses -- hanging on by a thread -- are being taxed for pandemic shortfalls…
Trump and Biden’s “Rare” Agreement

Trump and Biden’s “Rare” Agreement

Posted June 04, 2021

By Aaron Gentzler

“Trump and Biden don’t agree on much,” says our tech expert Ray Blanco. “So what’s bringing together both sides of the aisle?”
   When It Costs Too Much…

When It Costs Too Much…

Posted June 02, 2021

By Aaron Gentzler

Over the past 15 months, pharmaceutical companies have become keenly aware of China’s dominance…